Your browser doesn't support javascript.
loading
Recommendations for living donor kidney transplantation.
Frutos, Miguel Ángel; Crespo, Marta; Valentín, María de la Oliva; Alonso-Melgar, Ángel; Alonso, Juana; Fernández, Constantino; García-Erauzkin, Gorka; González, Esther; González-Rinne, Ana M; Guirado, Lluis; Gutiérrez-Dalmau, Alex; Huguet, Jorge; Moral, José Luis López Del; Musquera, Mireia; Paredes, David; Redondo, Dolores; Revuelta, Ignacio; Hofstadt, Carlos J Van-der; Alcaraz, Antonio; Alonso-Hernández, Ángel; Alonso, Manuel; Bernabeu, Purificación; Bernal, Gabriel; Breda, Alberto; Cabello, Mercedes; Caro-Oleas, José Luis; Cid, Joan; Diekmann, Fritz; Espinosa, Laura; Facundo, Carme; García, Marta; Gil-Vernet, Salvador; Lozano, Miquel; Mahillo, Beatriz; Martínez, María José; Miranda, Blanca; Oppenheimer, Federico; Palou, Eduard; Pérez-Saez, María José; Peri, Lluis; Rodríguez, Oscar; Santiago, Carlos; Tabernero, Guadalupe; Hernández, Domingo; Domínguez-Gil, Beatriz; Pascual, Julio.
Afiliação
  • Frutos MÁ; Nephrology Department, Hospital Regional Universitario de Málaga, Spain. Electronic address: miguel.frutos@gmail.com.
  • Crespo M; Nephrology Department, Hospital del Mar, Barcelona, Spain.
  • Valentín MO; National Transplant Organization, Madrid, Spain.
  • Alonso-Melgar Á; Paediatric Nephrology Department, Hospital La Paz, Madrid, Spain.
  • Alonso J; Nephrology Department, Hospital Regional Universitario de Málaga, Spain.
  • Fernández C; Nephrology Department, Hospital Universitario A Coruña, Spain.
  • García-Erauzkin G; Nephrology Department, Hospital Universitario de Cruces, Bilbao, Spain.
  • González E; Nephrology Department, Hospital Universitario 12 Octubre, Spain.
  • González-Rinne AM; Nephrology Department, Hospital Universitario de Canarias, Spain.
  • Guirado L; Nephrology Department, Fundacio Puigvert, Barcelona, Spain.
  • Gutiérrez-Dalmau A; Nephrology Department, Hospital Universitario Miguel Servet, Zaragoza, Spain.
  • Huguet J; RT Surgical Team, Fundació Puigvert, Barcelona, Spain.
  • Moral JLLD; Cantabria High Court Magistrate, Spain.
  • Musquera M; Urology Department, Hospital Clinic Universitari, Barcelona, Spain.
  • Paredes D; Donation and Transplantation Coordination Department, Hospital Clinic Universitari, Barcelona, Spain.
  • Redondo D; Nephrology Department, Hospital del Mar, Barcelona, Spain.
  • Revuelta I; Nephrology and RT Department, Hospital Clinic Universitari, Barcelona, Spain.
  • Hofstadt CJV; Hospital Psychology Unit, Hospital General Universitario de Alicante, Spain.
  • Alcaraz A; Urology Department, Hospital Clinic Universitari, Barcelona, Spain.
  • Alonso-Hernández Á; Nephrology Department, Hospital Universitario A Coruña, Spain.
  • Alonso M; Regional Transplantation Coordination, Seville, Spain.
  • Bernabeu P; Hospital Psychology Unit, Hospital General Universitario de Alicante, Spain.
  • Bernal G; Nephrology Department, Hospital Universitario Virgen del Rocío, Seville, Spain.
  • Breda A; RT Surgical Team, Fundació Puigvert, Barcelona, Spain.
  • Cabello M; Nephrology Department, Hospital Regional Universitario de Málaga, Spain.
  • Caro-Oleas JL; Immunology Department, Hospital Clinic i Universitari, Barcelona, Spain.
  • Cid J; Apheresis and Cell Therapy Unit, Haemotherapy and Haemostasis Department, Hospital Clinic Universitari, Barcelona, Spain.
  • Diekmann F; Nephrology and RT Department, Hospital Clinic Universitari, Barcelona, Spain.
  • Espinosa L; Paediatric Nephrology Department, Hospital La Paz, Madrid, Spain.
  • Facundo C; Nephrology Department, Fundacio Puigvert, Barcelona, Spain.
  • García M; National Transplant Organization, Madrid, Spain.
  • Gil-Vernet S; Nephrology Department, Hospital Universitari de Bellvitge, Barcelona, Spain.
  • Lozano M; Apheresis and Cell Therapy Unit, Haemotherapy and Haemostasis Department, Hospital Clinic Universitari, Barcelona, Spain.
  • Mahillo B; National Transplant Organization, Madrid, Spain.
  • Martínez MJ; Paediatric Urology Department, Hospital Universitario La Paz, Madrid, Spain.
  • Miranda B; Fundación Renal Iñigo Álvarez de Toledo, Madrid, Spain.
  • Oppenheimer F; Nephrology and RT Department, Hospital Clinic Universitari, Barcelona, Spain.
  • Palou E; Immunology Department, Hospital Clinic i Universitari, Barcelona, Spain.
  • Pérez-Saez MJ; Nephrology Department, Hospital del Mar, Barcelona, Spain.
  • Peri L; Urology Department, Hospital Clinic Universitari, Barcelona, Spain.
  • Rodríguez O; RT Surgical Team, Fundació Puigvert, Barcelona, Spain.
  • Santiago C; Nephrology Department, Hospital General de Alicante, Spain.
  • Tabernero G; Nephrology Department, Hospital Universitario de Salamanca, Spain.
  • Hernández D; Nephrology Department, Hospital Regional Universitario de Málaga, Spain.
  • Domínguez-Gil B; National Transplant Organization, Madrid, Spain.
  • Pascual J; Nephrology Department, Hospital del Mar, Barcelona, Spain. Electronic address: julpascual@gmail.com.
Nefrologia (Engl Ed) ; 42 Suppl 2: 5-132, 2022 Dec.
Article em En | MEDLINE | ID: mdl-36503720
This Guide for Living Donor Kidney Transplantation (LDKT) has been prepared with the sponsorship of the Spanish Society of Nephrology (SEN), the Spanish Transplant Society (SET), and the Spanish National Transplant Organization (ONT). It updates evidence to offer the best chronic renal failure treatment when a potential living donor is available. The core aim of this Guide is to supply clinicians who evaluate living donors and transplant recipients with the best decision-making tools, to optimise their outcomes. Moreover, the role of living donors in the current KT context should recover the level of importance it had until recently. To this end the new forms of incompatible HLA and/or ABO donation, as well as the paired donation which is possible in several hospitals with experience in LDKT, offer additional ways to treat renal patients with an incompatible donor. Good results in terms of patient and graft survival have expanded the range of circumstances under which living renal donors are accepted. Older donors are now accepted, as are others with factors that affect the decision, such as a borderline clinical history or alterations, which when evaluated may lead to an additional number of transplantations. This Guide does not forget that LDKT may lead to risk for the donor. Pre-donation evaluation has to centre on the problems which may arise over the short or long-term, and these have to be described to the potential donor so that they are able take them into account. Experience over recent years has led to progress in risk analysis, to protect donors' health. This aspect always has to be taken into account by LDKT programmes when evaluating potential donors. Finally, this Guide has been designed to aid decision-making, with recommendations and suggestions when uncertainties arise in pre-donation studies. Its overarching aim is to ensure that informed consent is based on high quality studies and information supplied to donors and recipients, offering the strongest possible guarantees.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transplante de Rim / Insuficiência Renal Crônica / Falência Renal Crônica Tipo de estudo: Guideline / Prognostic_studies Limite: Humans Idioma: En Revista: Nefrologia (Engl Ed) Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transplante de Rim / Insuficiência Renal Crônica / Falência Renal Crônica Tipo de estudo: Guideline / Prognostic_studies Limite: Humans Idioma: En Revista: Nefrologia (Engl Ed) Ano de publicação: 2022 Tipo de documento: Article